Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...

Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...

Through the collaboration, Applied StemCell is providing Syntax Bio with iPSC lines, including its GMP-compatible hypoimmune iPSC platform, which combines immune-evasion genome engineering with ...

Delve into the Open Building approach, promoting long-term stewardship and adaptability in architecture amid today's housing ...

Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

A pre-wedding video showing Pune realtor Ketan Agarwal joyfully celebrating with his fiancée Siya Goyal and her parents has ...

Historically characterized by excessive daytime sleepiness and cataplexy, narcolepsy is increasingly recognized as a ...

A road repair program designed for holistic city reconstruction was called into question by councilors Monday at a public works committee meeting in council chambers, 50 Town Square, Lima. If ...

The hottest new programming language is English. Andrej Karpathy, OpenAI co-founder and former Tesla AI director, said this ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...